Physician profile
Jay N Gross
NPI 1750470092
$8,378.98
in general payments reported to CMS, 2019-2025
11 companies · $4,436 in 2025
The $4,436 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $542 · 2020: $155 · 2021: $745 · 2022: $1,320 · 2023: $178 · 2024: $1,003 · 2025: $4,436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,169 · Travel and Lodging: $2,447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,169.11 |
| Travel and Lodging | $2,447.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,483.69 | 2021-2025 | Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $1,144.02 | 2019-2025 | Aveir, Perclose Prostyle |
| Biosense Webster, INC. | $1,079.71 | 2021-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro |
| Medtronic Vascular, INC. | $373.68 | 2019-2020 | |
| Biotronik INC. | $370.19 | 2021-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Renamic Neo |
| Boston Scientific Corporation | $316.54 | 2019-2022 | |
| Philips North America LLC | $240.22 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $155.15 | 2024 | Optimizer |
| Angiodynamics, INC. | $115.23 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.10 | 2024-2025 | Lifevest |
| Glaxosmithkline, LLC. | $13.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Gross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.